Ototoxic effects of cisplatin in a Sprague-Dawley rat animal model as revealed by ABR and transiently evoked otoacoustic emission measurements

Hearing Research

Volumn 170, Issue 1-2, 2002, Pages 70-82

  Hatzopoulos, Stavros ^a   Petruccelli, Joseph ^b   Laurell, Goran ^c   Avan, Paul ^d   Finesso, Mario ^e   Martini, Alessandro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Life Science and Bioengineering Center   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Laboratory of Sensory Biophysics   (France)

^e Fidia Advanced Biopolymers   (Italy)

Author keywords

Auditory brainstem response; Cisplatin; Otoacoustic emissions; Ototoxicity; Transiently evoked otoacoustic emission

Indexed keywords

CISPLATIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; AUDITORY RESPONSE; AUDITORY STIMULATION; BIOLOGICAL MODEL; BODY WEIGHT; BRAIN STEM RESPONSE; CLICK; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE CALCULATION; DOSE TIME EFFECT RELATION; EVOKED OTOACOUSTIC EMISSION; GENDER; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; RAT STRAIN;

ACOUSTIC STIMULATION; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; EAR DISEASES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 0036696953     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(02)00453-7     Document Type: Conference Paper

References (39)

1. Arruda J., Jung T.T., McGann D.G. Effect of leukotriene inhibitor on otoacoustic emissions in salicylate ototoxicity. Am. J. Otol. 17:1996;787-792.
2. Beck A., Mauer J., Welkoborsky H., Mann W. Changes in transitory evoked otoacoustic emissions in chemotherapy with cisplatin and 5FU. HNO. 40:1992;123-127.
3. Blakley B.W., Gupta A.K., Myers S.F., Schwan S. Risk factors for ototoxicity due to cisplatin. Arch. Otoryngol. Head Neck Surg. 120:1994;541-546.
4. Bourre J.M., Durand G., Erre J.P., Aran J.M. Changes in auditory brainstem evoked potentials in alpha-linolenic acid deficiency as a function of age in rats. Audiology. 38:1999;13-18.
5. Brownell W.E. Outer hair cell electromotility and otoacoustic emissions. Ear Hear. 11:1990;82-92.
6. Brownell W.E., Bader C.R., Bertrand D., de Ribaupierve Y. Evoked mechanical responses of isolated cochlear outer hair cells. Science. 227:1985;194-196.
7. Campbell C.M., Rybak L.P., Meech R.P., Hughes L. D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear. Res. 102:1996;90-98.
8. Efron, B., Tibshirani, R.J., 1993. An Introduction to the Bootstrap. Chapman and Hall, New York.
9. Ekborn A., Laurell G., Anderson A., Walin I., Eksborg S., Ehrsson H. Cisplatin induced hearing loss. Influence of mode of administration in the guinea pig. Hear. Res. 140:2000;38-44.
10. Fausti S.A., Schechter M.A., Rappaport B.Z., Frey R.H. Early detection of cisplatin ototoxicity. Cancer. 53:1984;224-231.
11. Fausti S.A., Frey R.H., Henry J.A., Olson D.J., Schaffer H.I. Early detection of ototoxicity using high-frequency tone-burst-evoked auditory brainstem responses. J. Am. Acad. Audiol. 3:1992;397-404.
12. Gandara D.R., Perez E.A., Weibe V., DeGregorio M.W. Cisplatin chemoprotection and rescue: Pharmacologic modulation of toxicity. Sem. Oncol. 18:1991;49-55.
13. Hatzopoulos S., Cheng J., Grzanka A., Martini A. Time frequency analyses of TEOAE recordings from normal and SNHL cases. Audiology. 39:2000;1-12.
14. Hatzopoulos, S., Di Stefano, M., Albertin, A., Martini, A., 1999. Evaluation of cisplatin ototoxicity in a rat animal model. In: Henderson, D., Salvi, R.J., Quaranta, A., McFadden, S.L., Burkard, R.F. (Eds.), Ototoxicity. Basic Science and Clinical Applications. Ann. NY Acad. Sci. New York 884, 211-225.
15. Hotz M.A., Harris F.P., Probst R. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope. 104:1994;1130-1134.
16. Husain K., Morris C., Whitworth C., Trammell G.L., Rybak L.P., Somani S.M. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol. Cell. Biochem. 178:1998;127-133.
17. Kersten L., Braunlich H., Keppler B.K., Gliesing C., Wendelin M., Westphal J. Comparative nephrotoxicity of some antitumour active platinum and rutherium complexes in rats. J. Appl. Toxicol. 18:1998;93-101.
18. Khvoles R., Freeman S., Sohmer H. Transient evoked otoacoustic emissions can be recorded in the rat. Hear. Res. 97:1996;120-126.
19. Khvoles R., Freeman S., Sohmer H. Development of transient evoked otoacoustic emissions in the neonatal rat. Audiol. Neurootol. 3:1998;40-53.
20. Kohn S.M., Fradis J., Zidan L., Podoshin E., Robinson E., Robinson I. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope. 98:1988;871-885.
21. Kopelman J., Budnick A.S., Kramer M.B., Sessions R.B. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope. 98:1988;858-864.
22. Laurell G., Bagger-Sjöbäck D. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol. 111:1991;891-898.
23. Laurell G., Jungnelius U. High dose cisplatin treatment. hearing loss and plasma concentrations. Laryngoscope. 100:1990;724-734.
24. McFadden D., Plattsmier H.S. Aspirin abolishes spontaneous oto-acoustic emissions. J. Acoust. Soc. Am. 76:1984;443-448.
25. Meech R.P., Campbell C.M., Hughes L.P., Rybak L.P. A semi-quantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear. Res. 124:1998;44-59.
26. Ravi R., Somani S., Rybak L. Mechanism of cisplatin ototoxicity. Antioxid. Syst. Pharm. Toxicol. 76:1995;384-386.
27. Riggs L.C., Brummett R.E., Guitjens S.K., Matz G.J. Ototoxicity resulting from combined administration of cisplatin and gentamicin. Laryngoscope. 106:1996;401-406.
28. Saito T., Aran J.M. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL. 56:1994;315-320.
29. Shera C.A., Guinan J.J. Evoked otoacoustic emissions arise by two fundamentally different mechanisms: a taxonomy for mammalian OAEs. J. Acoust. Soc. Am. 105:1999;782-798.
30. Sochalingam R., Freeman S., Cherny T.L., Sohmer H. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am. J. Otol. 21:2000;521-527.
31. Stengs C.H., Klis S.F., Huizing E.H., Smoorenburg G.F. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs. Hear. Res. 124:1998;108-117.
32. Stengs C.H., Klis S.F., Huizing E.H., Smoorenburg G.F. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs. Hear. Res. 124:1998;99-107.
33. Tange R., Vuzevski V.D. Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch. Otorhinolaryngol. 239:1982;41-47.
34. Tange R., Conijin A., Van Zeig I.L. Cortitoxic effects of cisplatin in the guinea pig. Arch. Otorhinolaryngol. 237:1982;17-26.
35. Taudy M., Syka J., Popelar J., Ulehlova L. Carboplatin and cisplatin ototoxicity in guinea pigs. Audiology. 31:1992;293-299.
36. Ueda, H., Sugiyama, K., Tashiro, S., Yokota, M., 1998. Mechanism of the protective effect of sodium malate on cisplatin-induced toxicity in mice. Biol. Pharm. Bull.
37. Withnell R.H., Yates G. Enhancement of the transient-evoked otoacoustic emission produced by the addition of a pure tone in the guinea pig. J. Acoust. Soc. Am. 104:1998;344-349.
38. Withnell R.H., Kirk D., Yates G. Otoacoustic emissions measured with a physically open recording system. J. Acoust. Soc. Am. 104:1998;350-355.
39. Zweig G., Shera C.A. The origin of periodicity in the spectrum of evoked otoacoustic emissions. J. Acoust. Soc. Am. 98:1995;2018-2047.